SCHEMBL40517

SCHEMBL40517

CNC(CCCCN)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.42
CXCR4 P61073 10/20 0.42
TSHR P16473 1/20 0.39
CHRM2 P08172 2/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SCN1A P35498 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
KCNA5 P22460 2/20 0.37
KCNH2 Q12809 1/20 0.37
SCN8A Q9UQD0 1/20 0.36
SLC6A3 Q01959 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNE1 P15382 1/20 0.36
CTSK P43235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL42821 0.98 CXCR4 (0.41) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL22275776 0.79 CXCR4 (0.48) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL3717619 0.78 LMNA (0.40) TSHRSCN8ASLC6A3
SCHEMBL21741385 0.78 HRH1 (0.49) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL5024095 0.77 HRH1 (0.47) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL2323123 0.76 KCNA5 (0.47) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL4582241 0.76 HRH1 (0.50) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL343645 0.75 HRH1 (0.41) HRH1CXCR4TSHRCHRM2SLC6A2
SCHEMBL4055323 0.75 TSHR (0.44) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL28622173 0.74 ALDH1A1 (0.46) TSHRCHRM2SLC6A2SLC6A4SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419408-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K. (JP) 2012-02-22 EP disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed
WO-2010119984-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-10-21 WO disclosed
WO-2010119984-A1 3-ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE IDO1, TPH1, AHR HRH1 56/4885CXCR4 2475/4885TSHR 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.